ETIFOXINE EG 50 mg, hard capsule 60 capsules
Active ingredients: Etifoxine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule60 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ETIFOXINE EG 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 60 gélule(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescription valid for up to 12 weeks
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66880843CIP73017300CIP133400930173008Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ÉTIFOXINEgélule | 50 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.